What is Accuray?
Accuray develops and manufactures advanced radiation oncology systems designed to deliver precise cancer treatment solutions. The company specializes in creating innovative medical devices that enable clinicians to target tumors with exceptional accuracy while minimizing exposure to surrounding healthy tissue. This focus on precision has shaped the organization's technical approach and product development strategy across its portfolio. Accuray's radiation oncology systems integrate sophisticated imaging, planning, and delivery technologies to support comprehensive cancer care. By combining real-time imaging capabilities with adaptive treatment planning, Accuray's platforms allow medical teams to adjust therapy in response to anatomical changes during treatment courses. This technological integration addresses a critical challenge in oncology: maintaining treatment efficacy while reducing potential side effects that can impact patient quality of life. Accuray serves hospitals, cancer treatment centers, and specialized radiation oncology facilities globally, supporting treatment of various cancer types across different anatomical sites.
How much funding has Accuray raised?
Accuray has raised a total of $500M across 5 funding rounds:
Stock Offering
$288M
Debt
$70M
Debt
$52M
Debt
$40M
Debt
$50M
Stock Issuance/Offering (2007): $288M, investors not publicly disclosed
Debt (2016): $70M led by Cerberus Business Finance, LLC
Debt (2017): $52M supported by MidCap Financial Trust
Debt (2017): $40M featuring MidCap Financial Trust
Debt (2025): $50M backed by Wingspire Capital
Key Investors in Accuray
MidCap Financial Trust
MidCap Financial Trust is a financial institution that has provided debt financing to Accuray. Their involvement suggests a focus on providing capital for established companies looking to manage their debt structure or fund specific operational needs.
Wingspire Capital
Wingspire Capital is a diversified specialty finance firm that provides innovative, one-stop financing solutions for middle market companies. Their participation in Accuray's funding round indicates a strategic interest in supporting companies with robust business models through customized debt financing.
Cerberus Business Finance, LLC
Cerberus Business Finance, LLC, a firm specializing in providing capital solutions, has invested in Accuray. Their backing highlights a strategic alignment with companies in the advanced technology and healthcare sectors requiring significant financial backing for growth and operations.
What's next for Accuray?
With its substantial total funding of $500M and the recent strategic investment of $50M, Accuray is well-positioned for its next phase of growth. The company's focus on precision in radiation oncology, coupled with its advanced technological integrations for adaptive treatment planning, suggests a strategic direction towards enhancing patient outcomes and expanding its global market reach. Future developments are likely to concentrate on further refining its existing platforms and potentially exploring new therapeutic modalities to address unmet needs in cancer care. This capital infusion will likely support research and development initiatives, bolster manufacturing capabilities, and strengthen its sales and distribution networks to solidify its competitive advantage in the medical device industry.
See full Accuray company page
